Metispharmaceuticals
1 known investors
Metis Pharmaceuticals (剂泰科技) is a biotech company using AI-driven nanomaterial innovation to develop targeted drug delivery and discovery platforms — including AiLNP for nanoparticle delivery design, AiRNA for mRNA sequence design, and AiTEM for small-molecule formulation design. Its technology enables precise LNP targeting of tissues such as liver, lung, muscle, and immune cells to create therapeutic opportunities for oncology, metabolic, autoimmune, and neurodegenerative diseases.
Founders & leadership
陈(
陈红敏 (Hongmin Chen)Co-founder
赖(
赖才达 (Caida Lai)Co-founder
王(
王文首 (Wenshou Wang)Co-founder
Investors · 1
Frequently asked questions
- What does Metispharmaceuticals do?
- Metis Pharmaceuticals (剂泰科技) is a biotech company using AI-driven nanomaterial innovation to develop targeted drug delivery and discovery platforms — including AiLNP for nanoparticle delivery design, AiRNA for mRNA sequence design, and AiTEM for small-molecule formulation design. Its technology enables precise LNP targeting of tissues such as liver, lung, muscle, and immune cells to create therapeutic opportunities for oncology, metabolic, autoimmune, and neurodegenerative diseases.
- Who founded Metispharmaceuticals?
- Metispharmaceuticals was founded by 陈红敏 (Hongmin Chen), 赖才达 (Caida Lai), 王文首 (Wenshou Wang).
- Who are Metispharmaceuticals's investors?
- Metispharmaceuticals's investors include Monolith Venture Advisory Limited.